Citigroup’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-82,846
Closed -$2.96M 7747
2014
Q4
$2.96M Buy
82,846
+41,690
+101% +$1.24M ﹤0.01% 2191
2014
Q3
$1.07M Buy
41,156
+223
+0.5% +$6.41K ﹤0.01% 2980
2014
Q2
$1.35M Sell
40,933
-12,477
-23% -$360K ﹤0.01% 2752
2014
Q1
$1.6M Sell
53,410
-19,900
-27% -$686K ﹤0.01% 2520
2013
Q4
$2.23M Buy
73,310
+28,251
+63% +$778K ﹤0.01% 2470
2013
Q3
$1.43M Buy
45,059
+5,464
+14% +$125K ﹤0.01% 2663
2013
Q2
$599K Buy
+39,595
New +$549K ﹤0.01% 3324

Other funds holding NPSP

Citigroup's NPSP Position: Q1 2015 in Review

Citigroup sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 82,846 shares — an estimated $2.96M sold.

Citigroup first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $2.96M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • Citigroup reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Citigroup sold 82,846 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $2.96M.
  • Citigroup first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Citigroup's NPS PHARMACEUTICALS INC position peaked at $2.96M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Citigroup's 13F filing for Q1 2015, filed 14 May 2015.